R&D 100 Award-Winning Bacterial Culture System Is Available From EMD Biosciences, Inc.; EMD Biosciences Attends 2004 R&D 100 Award Ceremony
10/19/2005 5:12:23 PM
EMD Biosciences, Inc. (www.emdbiosciences.com; EMD Biosciences), a major supplier of premium tools for proteomics and disease pathway analysis known through its global brands Calbiochem(R), Novabiochem(R), and Novagen(R), today announced that F. William Studier, a biophysicist at Brookhaven National Laboratory (www.bnl.gov/world), received a 2004 R&D 100 award for developing an improved system for high-density growth of bacterial cells to produce recombinant proteins. EMD Biosciences is part of the Life Science and Analytics (LSA) division of Merck KGaA (www.merck.de; Darmstadt, Germany) and operates as EMD Biosciences, Inc. in North America and Merck Biosciences outside North America.
comments powered by